International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
OpenCitations
Works that cite this article, indexed by OpenCitations.
No retinopathy after orbital irradiation in patients with thyroid eye disease – a follow up study
Frontiers in Endocrinology 16 (2025)
Sara Makhoul; Janos K. Aranyosi; Emese Csiki; Hilda Urbancsek; Edit B. Nagy; Annamaria Erdei; Mariann Fodor; Arpad Kovacs; Endre V. Nagy; Bernadett Ujhelyi
Early Low‐Dose Rituximab for Mild‐to‐Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety
International Journal of Endocrinology 2026(1) (2026)
Ming Lu; Luqiang Wang; Xuelian Zhang
Is concomitant treatment with steroids and radiotherapy more favorable than sequential treatment in moderate-to-severe graves orbitopathy?
La radiologia medica 126(2) (2020)
Paolo P. Limone; Lavinia Bianco; Marco Mellano; Francesca Garino; Fabiana Giannoccaro; Annalisa Rossi; Claudia Airaldi; Daniela Nassisi; Eva Gino; Maurilio Deandrea; Bruno Oldani; Maria Grazia Ruo Redda
Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review
Ophthalmology and Therapy 9(1) (2019)
Nickisa M. Hodgson; Fatemeh Rajaii
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review
Endocrine 85(2) (2024)
Martina Verrienti; Irene Gagliardi; Luisa Valente; Antonio Stefanelli; Luca Borgatti; Elena Franco; Manlio Galiè; Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio
L’orbitopathie basedowienne: diagnostic, épidémiologie et principes de traitement
La Revue de Médecine Interne 43(4) (2022)
A. Yan Lun; M. Le Bras; E. Scharbarg; P. Morcel; S. Hadjadj; P. Lebranchu; D. Drui
Changes in therapeutic response, ocular manifestations of Graves’ orbitopathy and quality of life during the first year after orbital radiotherapy
International Ophthalmology 43(11) (2023)
Mariya Asenova Stoynova; Alexander Dimitrov Shinkov; Miroslav Todorov Novoselski; Victoria Vladimirova Petrova; Inna Dimitrova Dimitrova; Inna Angelova Yankova; Roussanka Dimitrova Kovatcheva
Improvement of the MRI and clinical features of Asian Graves’ ophthalmopathy by radiation therapy with steroids
Japanese Journal of Radiology 37(8) (2019)
Zichang Ma; Hiroshi Ozaki; Yojiro Ishikawa; Keiichi Jingu
Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy
Current Neurology and Neuroscience Reports 22(6) (2022)
Tracy J. Lu; Linus Amarikwa; Connie M. Sears; Andrea L. Kossler
Current Role and Historical Roots of Radiotherapy in Thyroid Eye Disease
International Ophthalmology Clinics 61(2) (2021)
Jonathan Siktberg; Rachel K. Sobel
Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy
Best Practice & Research Clinical Endocrinology & Metabolism 34(1) (2020)
Terry J. Smith
Teprotumumab: a novel therapeutic monoclonal antibody for thyroid-associated ophthalmopathy
Expert Opinion on Investigational Drugs 29(7) (2020)
Dane H. Slentz; Christine C. Nelson; Terry J. Smith
Thyroid eye disease: Redefining its management—A review
Clinical & Experimental Ophthalmology 49(2) (2021)
Amy P. Jain; Pimkwan Jaru‐Ampornpan; Raymond S. Douglas
A novel treatment for malignant spasticity: The therapeutic use of stereotactic radiosurgery (SRS)
Radiotherapy and Oncology 169 (2022)
Luca Nicosia; Elena Rossato; Renato Avesani; Fabio Marchioretto; Giuseppe Armani; Massimo Zamperini; Giovanni Foti; Fatemeh Jafari; Antonio De Simone; Ruggero Ruggieri; Filippo Alongi; Federico Ferrari
<p>Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm</p>
Therapeutics and Clinical Risk Management Volume 15 (2019)
Yao Wang; Amy Patel; Raymond S Douglas